A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole XR (Extended Release) in Patients With Restless Legs Syndrome.
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Ropinirole (Primary)
- Indications Restless legs syndrome
- Focus Registrational; Therapeutic Use
- 20 Mar 2007 Results published as abstract and presented at AAN in Apr 2007.
- 07 Aug 2006 Status change
- 29 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History